S961 is a potent peptide insulin receptor antagonist. It affects PI3K/AKT and MAPK signaling by blocking the InsR signaling cascade, effectively inhibiting insulin-induced cell proliferation and colony formation.
S961 MOA:Targeting Insulin Receptor/PI3K-AKT Pathway for Diabetes and Metabolic Syndrome
S961 is a potent peptide insulin receptor antagonist. It affects PI3K/AKT and MAPK signaling by blocking the InsR signaling cascade, effectively inhibiting insulin-induced cell proliferation and colony formation.